131 related articles for article (PubMed ID: 16264822)
1. Are circulating tumor cells an independent prognostic factor in patients with high-risk melanoma?
Hoon DS
Nat Clin Pract Oncol; 2004 Dec; 1(2):74-5. PubMed ID: 16264822
[No Abstract] [Full Text] [Related]
2. [Prognostic significance of some markers in cutaneous melanoma treated with different therapeutic modalities].
Nepomniashchaia EM; Gusareva MA; Petrov SV
Vopr Onkol; 2008; 54(6):744-8. PubMed ID: 19241851
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial.
Schmidt H; Suciu S; Punt CJ; Gore M; Kruit W; Patel P; Lienard D; von der Maase H; Eggermont AM; Keilholz U; ;
J Clin Oncol; 2007 Apr; 25(12):1562-9. PubMed ID: 17443000
[TBL] [Abstract][Full Text] [Related]
4. Isolated tumor cells and long-term prognosis of patients with melanoma.
van Akkooi AC; de Wilt JH; Verhoef C; Eggermont AM
Ann Surg Oncol; 2008 May; 15(5):1547-8. PubMed ID: 18197454
[No Abstract] [Full Text] [Related]
5. Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?
Schuchter LM
J Clin Oncol; 2004 Jan; 22(1):7-10. PubMed ID: 14665612
[No Abstract] [Full Text] [Related]
6. Molecular detection of circulating tumor cells is an independent prognostic factor in patients with high-risk cutaneous melanoma.
Mocellin S; Del Fiore P; Guarnieri L; Scalerta R; Foletto M; Chiarion V; Pilati P; Nitti D; Lise M; Rossi CR
Int J Cancer; 2004 Sep; 111(5):741-5. PubMed ID: 15252844
[TBL] [Abstract][Full Text] [Related]
7. Present status and future prospects for adjuvant therapy of melanoma: time to build upon the foundation of high-dose interferon alfa-2b.
Moschos SJ; Kirkwood JM; Konstantinopoulos PA
J Clin Oncol; 2004 Jan; 22(1):11-4. PubMed ID: 14665613
[No Abstract] [Full Text] [Related]
8. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
[TBL] [Abstract][Full Text] [Related]
9. Lymphangiogenesis induced by surgery: a risk for melanoma metastasis.
Rebora A
Arch Dermatol; 2009 Jan; 145(1):89; author reply 90. PubMed ID: 19153355
[No Abstract] [Full Text] [Related]
10. How melanoma is treated in real life.
Dummer R; Schadendorf D
Arch Dermatol; 2008 May; 144(5):664-5. PubMed ID: 18490596
[No Abstract] [Full Text] [Related]
11. Enhanced photoacoustic detection of melanoma cells using gold nanoparticles.
McCormack DR; Bhattacharyya K; Kannan R; Katti K; Viator JA
Lasers Surg Med; 2011 Apr; 43(4):333-8. PubMed ID: 21500228
[TBL] [Abstract][Full Text] [Related]
12. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
[TBL] [Abstract][Full Text] [Related]
13. Molecular staging by multimarker reverse transcriptase-polymerase chain reaction assay of lymphatic drainage and blood from melanoma patients after lymph node dissection.
Rutkowski P; Nowecki ZI; Kulik J; Ruka W; Siedlecki JA
Melanoma Res; 2008 Aug; 18(4):246-52. PubMed ID: 18626308
[TBL] [Abstract][Full Text] [Related]
14. Chemosurgery for invasive melanoma.
Brooks NA
Dermatol Surg; 2010 Feb; 36(2):237-40. PubMed ID: 20039917
[No Abstract] [Full Text] [Related]
15. [Cutaneous melanoma].
Eigentler TK; Mügge LO; Bembenek A; Garbe C
Hautarzt; 2007 Oct; 58(10):885-97; quiz 898. PubMed ID: 17973138
[TBL] [Abstract][Full Text] [Related]
16. Isolated limb perfusion in regional melanoma.
Noorda EM; Vrouenraets BC; Nieweg OE; Kroon BB
Surg Oncol Clin N Am; 2006 Apr; 15(2):373-84. PubMed ID: 16632221
[TBL] [Abstract][Full Text] [Related]
17. [Adjuvant chemotherapy as a component of complex treatment for skin melanoma].
Kudriavtsev DV; Kudriavtseva GT; Mardynskiĭ IuS
Vopr Onkol; 2008; 54(2):170-7. PubMed ID: 18522165
[TBL] [Abstract][Full Text] [Related]
18. Markers of high-risk cutaneous melanoma: is there a winning combination for individualized prognosis?
Carlson JA; Ross J; Murphy M
J Cutan Pathol; 2005 Nov; 32(10):700-3. PubMed ID: 16293184
[No Abstract] [Full Text] [Related]
19. Measurement of matrix metalloproteinases in serum of patients with melanoma: snarled in technical pitfalls.
Zucker S; Cao J
Clin Cancer Res; 2005 Jul; 11(14):5069-70. PubMed ID: 16033818
[No Abstract] [Full Text] [Related]
20. Melanoma presenting as circulating tumor cells associated with failed angiogenesis.
Lee RT; Fallarino F; Ashikari A; Gajewski TF
Melanoma Res; 2008 Aug; 18(4):289-94. PubMed ID: 18626315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
